Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2022
/
Article
/
Tab 2
/
Research Article
[Retracted] Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
Table 2
Comparison of blood pressure, HbA1c, and LDL-C levels (
).
Indices
Control group (
)
Dapagliflozin group (
)
value
value
Systolic blood pressure (mmHg)
Upon admission
128.8614.24
22.387
0.49
After 20 weeks of treatment
126.0813.15
30.301
0.78
Diastolic blood pressure (mmHg)
Upon admission
38.021
0.96
After 20 weeks of treatment
20.896
1.16
HbA1c (%)
Upon admission
51.056
0.83
After 20 weeks of treatment
69.058
0.94
LDL-C (mm01/L)
Upon admission
40.340
0.06
After 20 weeks of treatment
43.321
0.01